Experimental drug tested for debilitating fatigue condition
NCT ID NCT00215813
Summary
This study is testing an experimental drug called Ampligen in adults with severely debilitating chronic fatigue syndrome (CFS). Participants receive the drug through regular infusions but are responsible for paying all treatment-related costs themselves. The goal is to see if Ampligen can help control the disease and improve patients' ability to function in daily life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC FATIGUE SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hunter-Hopkins Center, PA
Charlotte, North Carolina, 28210, United States
-
Sierra Internal Medicine
Incline Village, Nevada, 89451, United States
Conditions
Explore the condition pages connected to this study.